Overview

Sleep Disorders in Chronic Kidney Disease Patients

Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
1. Asses sleep disorders in CKD patients and those on haemodialysis and related complications ( uncontrolled blood pressure,glomerular filtration rate (GFR) ,proteinuria and psychological disturbance) 2. Asses effect of hypnotics or sedations for 3 month in improvement those complications after taking treatment .
Phase:
Phase 1
Details
Lead Sponsor:
Assiut University
Treatments:
Quetiapine Fumarate